NCT02722200View on ClinicalTrials.gov

Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 19, 2017

Study Completion Date

July 19, 2017

Conditions
Obesity
Interventions
DRUG

hydrocortisone

Hydrocortisone will be used as the steroid of choice because it is bio-identical to cortisol and is subject to the same metabolism as cortisol.

OTHER

saline

Saline will be used as the placebo comparator. It will be administered in the same manner as the active drug.

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER

NCT02722200 - Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger | Biotech Hunter | Biotech Hunter